AI in Oncology: Current and Future Applications
AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
Diagnosis & Disease Information
Final Results of DREAMM-2 Show Durable Responses With Belantamab Mafodotin
Final results from the DREAMM-2 trial suggest that belantamab mafodotin produces durable responses in patients with relapsed/refractory multiple myeloma.
Aphexda Approved for Stem Cell Mobilization in Multiple Myeloma
Aphexda (motixafortide) is expected to be available later this month.
The Challenge of Making Cancer Trials More Diverse
Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse.
Melflufen Demonstrates Efficacy in LIGHTHOUSE Trial; Drug’s Future Still Unclear
Melflufen plus daratumumab and dexamethasone produced better outcomes than daratumumab alone in a phase 3 trial of patients with relapsed/refractory multiple myeloma.
Oral Mezigdomide and Dexamethasone Proves Active in Rel/Ref Multiple Myeloma
The combination of oral mezigdomide and dexamethasone has shown activity in patients with relapsed/refractory multiple myeloma.
Some Immunosuppressed Patients Lack Anti-Spike Antibodies After Multiple COVID-19 Vaccinations
About 1 in 5 immunosuppressed individuals have no detectable IgG anti-spike antibodies after 3 or more COVID-19 vaccinations, a new study suggests.
Mask Mandates Have Kept One Cancer Center Free From COVID-19. Others Have Lifted Masking Requirements Despite Patient Concerns
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Lack of Representation in Studies May Impact MM Guidelines
Black patients are underrepresented in studies of multiple myeloma used to support IMWG guidelines, researchers found.
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...